[Federal Register Volume 65, Number 23 (Thursday, February 3, 2000)]
[Notices]
[Pages 5369-5370]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-2331]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-814 (Final)]


Creatine Monohydrate From China

Determination

    On the basis of the record \1\ developed in the subject 
investigation, the United States International Trade Commission 
determines, pursuant to section 735(b) of the Tariff Act of 1930 (19 
U.S.C. Sec. 1673d(b)) (the Act), that an industry in the United States 
is materially injured by reason of imports from China of creatine 
monohydrate, provided for in

[[Page 5370]]

subheading 2925.20.90 of the Harmonized Tariff Schedule of the United 
States, that have been found by the Department of Commerce to be sold 
in the United States at less than fair value (LTFV).\2\ The Commission 
made a negative determination concerning critical circumstances.
---------------------------------------------------------------------------

    \1\ The record is defined in sec. 207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR Sec. 207.2(f)).
    \2\ Commissioner Deanna Tanner Okun did not participate in this 
investigation.
---------------------------------------------------------------------------

Background

    The Commission instituted this investigation effective February 12, 
1999, following receipt of a petition filed with the Commission and the 
Department of Commerce by Pfanstiehl Laboratories, Inc., Waukegan, IL. 
The final phase of the investigation was scheduled by the Commission 
following notification of a preliminary determination by the Department 
of Commerce that imports of creatine monohydrate from China were being 
sold at LTFV within the meaning of section 733(b) of the Act (19 U.S.C. 
Sec. 1673b(b)). Notice of the scheduling of the Commission's 
investigation and of a public hearing to be held in connection 
therewith was given by posting copies of the notice in the Office of 
the Secretary, U.S. International Trade Commission, Washington, DC, and 
by publishing the notice in the Federal Register of August 19, 1999 (64 
FR 45275). The hearing was held in Washington, DC, on December 16, 
1999, and all persons who requested the opportunity were permitted to 
appear in person or by counsel.
    The Commission transmitted its determination in this investigation 
to the Secretary of Commerce on January 28, 2000. The views of the 
Commission are contained in USITC Publication 3272 (January, 2000), 
entitled Creatine Monohydrate from China (Investigation No. 731-TA-814 
(Final)).

    By order of the Commission.

    Issued: January 28, 2000.
Donna R. Koehnke,
Secretary.
[FR Doc. 00-2331 Filed 2-2-00; 8:45 am]
BILLING CODE 7020-01-P